| PERIOD ENDING | 30-Sep-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 246,343 | 226,159 | 225,292 | 240,391 | | Cost of Revenue | 73,350 | 73,806 | 79,278 | 83,325 | | | Gross Profit | 172,993 | 152,353 | 146,014 | 157,066 | | | Operating Expenses | | Research Development | 48,826 | 46,562 | 44,752 | 48,361 | | Selling General and Administrative | 98,592 | 93,068 | 89,080 | 101,299 | | Non Recurring | 6,274 | 6,909 | 9,788 |
-
| | Others | 4,110 | 3,827 | 3,815 | 3,868 | | | | Total Operating Expenses | 157,802 | 150,366 | 147,435 |
-
| | | | Operating Income or Loss | 15,191 | 1,987 | (1,421) | 3,538 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,073 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 16,264 | 1,987 | (1,421) | 3,538 | | Interest Expense | 1,385 | 491 | 250 | 1,071 | | Income Before Tax | 14,879 | 1,496 | (1,671) | 2,467 | | Income Tax Expense | (1,021) | (2,292) | (8,846) | (2,192) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,900 | 3,788 | 7,175 | 4,659 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,900 | 3,788 | 7,175 | 4,659 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,900 | $3,788 | $7,175 | $4,659 |
|
1.48% Nasdaq 
Income Statement
